Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies

Nutrients. 2023 Jan 28;15(3):668. doi: 10.3390/nu15030668.

Abstract

Inflammatory Bowel Disease (IBD) includes a spectrum of chronic immune-mediated intestinal diseases thought to be related to the complex interaction between the host immune system and the intestinal microbiome. Research supports the use of nutritional therapy in IBD; however, it is not routinely used in clinical practice. This literature review seeks to advance the understanding of diet and its effect in IBD with a focus on both Crohn's Disease (CD) and Ulcerative Colitis (UC). The contribution of diet to the development and treatment of IBD cannot be overstated. In both pediatric as well as adult IBD, nutritional interventions have been shown to improve clinical symptoms as well as inflammatory burden. The impact of dietary intervention is best exemplified through the use of Exclusive Enteral Nutrition (EEN) in CD. EEN and clinical research on exclusionary whole food diets-Crohn's Disease Exclusion Diet (CDED), Specific Carbohydrate Diet (SCD), low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, and Mediterranean Diet-are discussed within this review. Current clinical literature supports the elimination of detrimental components and the incorporation of low processed whole foods in the diet. Additional prospective and longitudinal dietary studies on sustainable and long-term dietary options, along with a deeper understanding of the mechanism, are needed to further advance the role of nutritional interventions in IBD.

Keywords: Crohn’s disease; Crohn’s disease exclusion diet; FODMAP; Mediterranean diet; exclusive enteral nutrition; inflammatory bowel disease; specific carbohydrate diet; ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Adult
  • Child
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Diet
  • Diet, Mediterranean*
  • Humans
  • Inflammatory Bowel Diseases* / therapy
  • Prospective Studies

Grants and funding

This research received no external funding.